Quality improvement: A strategy to accelerate pharmacist integration into team-based primary care practice

Jorgenson D Dalton D Farrell B Tsuyuki RT Dolovich L . Guidelines for pharmacists integrating into primary care teams. Can Pharm J (Ott) 2013;146(6):342-52.

Langley G Moen R Nolan K Nolan T Norman C Provost L . The improvement guide: a practical approach to enhancing organizational performance. 2nd ed. San Francisco (CA): Jossey-Bass; 2009.

Healthcare revolutionized: Women’s College Hospital strategy 2018-2022 . 2018. Available: http://wchstrategy.womenscollegehospital.ca/ (accessed July 15, 2020).

World Health Organization. WHO global patient safety challenge: medication without harm. 2017. Available: https://www.who.int/patientsafety/medication-safety/medication-without-harm-brochure/en/ (accessed April 4, 2019).

Farrell B Black C Thompson W , et al. Deprescribing antihyperglycemic agents in older persons. Can Fam Physician 2017;63(11):832.

Farrell B Pottie K Thompson W , et al. Deprescribing proton pump inhibitors. Can Fam Physician 2017;63(5):354.

Bjerre LM Farrell B Hogel M , et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Can Fam Physician 2018;64(1):17.

Pottie K Thompson W Davies S , et al. Deprescribing benzodiazepine receptor agonists. Can Fam Physician 2018;64(5):339.

Reeve E Farrel B Thompson W , et al. Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine. 2018. Available: http://sydney.edu.au/medicine/cdpc/documents/resources/deprescribing-recommendations.pdf (accessed May 5, 2019).

Batuwitage BT Kingham JGC Morgan NE Bartlett RL . Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007;83(975):66-8.

Heidelbaugh JJ Goldberg KL Inadomi JM . Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care 2010;16(9):e228-234.

Walsh K Kwan D Marr P Papoushek C Lyon WK . Deprescribing in a family health team: a study of chronic proton pump inhibitor use. J Prim Health Care 2016;8(2):164.

Elwyn G Frosch D Thomson R , et al. Shared decision making: a model for clinical practice. J Gen Intern Med 2012;27(10):1361-7.

Tannenbaum C . Do I stil need this medication? (Proton pump inhibitor). 2014]. Available: www.deprescribingnetwork.ca/useful-resources (accessed May 21, 2019).

Jorgenson D Laubscher T Lyons B Palmer R . Integrating pharmacists into primary care teams: barriers and facilitators: primary care team pharmacist integration. Int J Pharm Pract 2014;22(4):292-9.

Linsky A Meterko M Stolzmann K Simon SR . Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing. BMC Health Serv Res 2017;17(1):447.

Rosenthal M Austin Z Tsuyuki RT . Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J (Ott) 2010;143(1):37-42.

Gregory PAM Teixeira B Austin Z . What does it take to change practice? Perspectives of pharmacists in Ontario. Can Pharm J (Ott) 2018;151(1): 43-50.

Famiyeh I-M . Pharmacy service users’ support for and willingness to use community pharmacist prescribing services in Ontario. November 2017. Available: http://hdl.handle.net/1807/79397 (accessed April 4, 2019).

Langford BJ Jorgenson D Kwan D Papoushek C . Implementation of a self-administered questionnaire to identify patients at risk for medication-related problems in a family health center. Pharmacotherapy 2006;26(2): 260-8.

Farrell B Dolovich L Austin Z Connie S . Implementing a mentorship program for pharmacists integrating into family practice: practical experience from the IMPACT project team. Can Pharm J (Ott) 2010;143(1):28-36.